NP39724b Pomalidomide and Thalidomide

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£960K
Sector
HEALTH
Published
29 Jan 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act

Geochart for 1 buyers and 6 suppliers
NHS National Services Scotland NSS
Bristol Myers Squibb Pharmaceuticals
Teva
Thornton & Ross
Wockhardt
Zentiva
Accord
+−
Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

1 buyer

6 suppliers

Description

Supply of pomalidomide capsules and thalidomide capsules to NHS Scotland.

Total Quantity or Scope

Supply of pomalidomide and thalidomide capsules to NHS Scotland. The Authority has awarded the Framework Agreement as an unranked multi-supplier framework agreement per line to six (6) Framework Participants.

Award Detail

1 Bristol Myers Squibb Pharmaceuticals (London)
  • Reference: 002990-2025-1
  • Value: £959,680 [share]
  • Awarded to group of suppliers.
2 Teva (Castleford)
  • Reference: 002990-2025-1
  • Value: £959,680 [share]
  • Awarded to group of suppliers.
3 Thornton & Ross (Huddersfield)
  • Reference: 002990-2025-1
  • Value: £959,680 [share]
  • Awarded to group of suppliers.
4 Wockhardt (Wrexham)
  • Reference: 002990-2025-1
  • Value: £959,680 [share]
  • Awarded to group of suppliers.
5 Zentiva (Guildford England)
  • Reference: 002990-2025-1
  • Value: £959,680 [share]
  • Awarded to group of suppliers.
6 Accord (Devon)
  • Reference: 002990-2025-1
  • Value: £959,680 [share]
  • Awarded to group of suppliers.

Award Criteria

Pregnancy Prevention Programme (PPP) 15
price 85

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.I.7 and Section V.2.4 cover the twelve (12) month Framework Agreement duration and the thirty-six (36) month extension period of the Framework Agreement. (SC Ref:789054)

Reference

Domains